Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A phase 2 study of rituximab, bendamustine, bortezomib and dexamethasone for first-line treatment of older patients with mantle cell lymphoma.
Gressin R, Daguindau N, Tempescul A, Moreau A, Carras S, Tchernonog E, Schmitt A, Houot R, Dartigeas C, Pignon JM, Corm S, Banos A, Mounier C, Dupuis J, Macro M, Fleury J, Jardin F, Sarkozy C, Damaj G, Feugier P, Fornecker LM, Chabrot C, Dorvaux V, Bouadallah K, Amorin S, Garidi R, Voillat L, Joly B, Celigny PS, Morineau N, Moles MP, Zerazhi H, Fontan J, Arkam Y, Alexis M, Delwail V, Vilque JP, Ysebaert L, Le Gouill S, Callanan MB; Lymphoma Study Association. Gressin R, et al. Among authors: carras s. Haematologica. 2019 Jan;104(1):138-146. doi: 10.3324/haematol.2018.191429. Epub 2018 Aug 31. Haematologica. 2019. PMID: 30171024 Free PMC article. Clinical Trial.
Adult patients with de novo acute myeloid leukemia show a functional deregulation of redox balance at diagnosis which is correlated with molecular subtypes and overall survival.
Mondet J, Presti CL, Garrel C, Skaare K, Mariette C, Carras S, Park S, Carré M, Bulabois CE, Molina L, Gressin R, Thiebaut A, Courby S, Socoro-Yuste N, Faure P, Leer-Florin AM, Cahn JY, Mossuz P. Mondet J, et al. Among authors: carras s. Haematologica. 2019 Sep;104(9):e393-e397. doi: 10.3324/haematol.2018.206821. Epub 2019 Feb 28. Haematologica. 2019. PMID: 30819920 Free PMC article. No abstract available.
Extranucleolar CYCLON Staining Pattern Is Strongly Associated to Relapse/Refractory Disease in R-CHOP-treated DLBCL.
Bouroumeau A, Bussot L, Sartelet H, Fournier C, Betton-Fraisse P, Col E, David-Boudet L, McLeer A, Lefebvre C, Raskovalova T, Jacob MC, Vettier C, Chevalier S, Algrin C, Carras S, Gressin R, Callanan MB, Bonnefoix T, Emadali A. Bouroumeau A, et al. Among authors: carras s. Hemasphere. 2021 Jun 12;5(7):e598. doi: 10.1097/HS9.0000000000000598. eCollection 2021 Jul. Hemasphere. 2021. PMID: 34131636 Free PMC article. No abstract available.
CYCLON and NPM1 Cooperate within an Oncogenic Network Predictive of R-CHOP Response in DLBCL.
Bouroumeau A, Bussot L, Hamaidia S, Garcìa-Sandoval A, Bergan-Dahl A, Betton-Fraisse P, Duley S, Fournier C, Aucagne R, Adrait A, Couté Y, McLeer A, Col E, David-Boudet L, Raskovalova T, Jacob MC, Vettier C, Chevalier S, Carras S, Lefebvre C, Algrin C, Gressin R, Callanan MB, Sartelet H, Bonnefoix T, Emadali A. Bouroumeau A, et al. Among authors: carras s. Cancers (Basel). 2021 Nov 24;13(23):5900. doi: 10.3390/cancers13235900. Cancers (Basel). 2021. PMID: 34885010 Free PMC article.
Long-term analysis of the RiBVD phase II trial reveals the unfavorable impact of TP53 mutations and hypoalbuminemia in older adults with mantle cell lymphoma; for the LYSA group.
Carras S, Torroja A, Emadali A, Montaut E, Daguindau N, Tempescul A, Moreau A, Tchernonog E, Schmitt A, Houot R, Dartigeas C, Barbieux S, Corm S, Banos A, Fouillet L, Dupuis J, Macro M, Fleury J, Jardin F, Sarkozy C, Damaj G, Feugier P, Fornecker LM, Chabrot C, Dorvaux V, Bouabdallah K, Amorim S, Garidi R, Voillat L, Joly B, Morineau N, Moles MP, Zerazhi H, Fontan J, Arkam Y, Alexis M, Delwail V, Vilque JP, Ysebaert L, Burroni B, Callanan M, Le Gouill S, Gressin R. Carras S, et al. Haematologica. 2023 Nov 30. doi: 10.3324/haematol.2023.283724. Online ahead of print. Haematologica. 2023. PMID: 38031755 Free article.
Trastuzumab for treatment of refractory/relapsed HER2-positive adult B-ALL: results of a phase 2 GRAALL study.
Chevallier P, Robillard N, Charbonnier A, Raffoux E, Maury S, Carras S, Chabrot C, Fohrer C, Bernard M, Blade JS, Etienne A, Talmant P, Delaunay J, Guillaume T, Mohty M, Bene MC, Ifrah N, Dombret H. Chevallier P, et al. Among authors: carras s. Blood. 2012 Mar 15;119(11):2474-7. doi: 10.1182/blood-2011-11-390781. Epub 2012 Jan 20. Blood. 2012. PMID: 22267607 Free article. Clinical Trial.
Adverse outcome in follicular lymphoma is associated with MYC rearrangements but not MYC extra copies.
Bussot L, Chevalier S, Cristante J, Grange B, Tesson B, Deteix-Santana C, Orsini-Piocelle F, Leyronnas C, Dupire S, Gressin R, Salles G, Bachy E, Emadali A, Valmary-Degano S, Huet S, Lefebvre C, Carras S. Bussot L, et al. Among authors: carras s. Br J Haematol. 2021 Jul;194(2):382-392. doi: 10.1111/bjh.17550. Epub 2021 Jun 21. Br J Haematol. 2021. PMID: 34155628
31 results